William McNamee

Private Equity Investor chez Tarnagulla Ventures Pty Ltd.

Profil

William has been a Director of Tarnagulla Ventures Pty Ltd since 2016.
During his time he has also co-founded and led the development on three life sciences companies, Holman Pharmaceuticals, Dalmoral Pharmaceuticals, and LimRad Therapeutics.
Prior to this he was VP of Business Development at Premneo Pharmaceuticals, a clinical stage rare disease company.
William started his career at Goldman Sachs Group in New York in the Securities division and has a B.A.
in Economics from Harvard University.

Postes actifs de William McNamee

Sociétés	Poste	Début
Tarnagulla Ventures Pty Ltd.	Private Equity Investor	01/03/2016

Formation de William McNamee

Harvard University

Undergraduate Degree